Oscar Health Inc (NYSE:OSCR) price on Thursday, February 27, fall -5.62% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $14.79.
A look at the stock’s price movement, the close in the last trading session was $15.67. Turning to its 52-week performance, $23.79 and $12.43 were the 52-week high and 52-week low respectively. Overall, OSCR moved -9.15% over the past month.
Oscar Health Inc’s market cap currently stands at around $3.71 billion, with investors looking forward to this quarter’s earnings report slated for in March.
Analysts have a consensus estimate of 2.84B for the company’s revenue for the quarter, with a low and high estimate of 2.77B and 2.94B respectively. The average forecast suggests up to a 32.37% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 11.36B, representing a 23.79% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that OSCR is a 50% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
5 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 2 analyst(s) rate the stock as a Hold, 3 recommend OSCR as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
OSCR’s current price about -2.81% and -0.67% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 47.17, while 7-day volatility ratio is 8.51% and 7.90% in the 30-day chart. Further, Oscar Health Inc (OSCR) has a beta value of 1.74, and an average true range (ATR) of 1.18. Analysts have given the company’s stock an average 52-week price target of $21, forecast between a low of $5 and high of $28. Looking at the price targets, the low is 66.19% off current price level while to achieve the yearly target high, price needs to move -89.32%. Nonetheless, investors will most likely welcome a -41.99% jump to $21 which is the analysts’ median price.
If we refocus on Oscar Health Inc (NYSE:OSCR), historical trading data shows that trading volumes averaged 4.32 million over the past 3 months. The company’s latest data on shares outstanding shows there are 214.97 million shares.
The 29.54% of Oscar Health Inc’s shares are in the hands of company insiders while institutional holders own 65.33% of the company’s shares. Current price change has pushed the stock 10.04% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the OSCR stock continues to rise going into the next quarter.
